Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease

Brain Pathology

Volumn 18, Issue 2, 2008, Pages 225-238

  Zuccato, Chiara ^a   Marullo, Manuela ^a   Conforti, Paola ^a   MacDonald, Marcy E ^b   Tartari, Marzia ^a   Cattaneo, Elena ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

BDNF; Human brain; Huntington's disease; p75NTR; T Sch; TrkB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; BRAIN RECEPTOR; MESSENGER RNA; NEUROTROPHIN RECEPTOR P75; PROTEIN;

ADULT; ARTICLE; AUTOPSY; BRAIN CORTEX; CAUDATE NUCLEUS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HUNTINGTON CHOREA; MALE; NERVE DEGENERATION; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RECEPTOR AFFINITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SYMPTOM;

AGED; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; POSTMORTEM CHANGES; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKB; SEVERITY OF ILLNESS INDEX;

EID: 41149120252     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2007.00111.x     Document Type: Article

References (61)

1. Alberch J, Lopez M, Badenas C, Carrasco JL, Mila M, Munoz E, Canals JM (2005) Association between BDNF val66met polymorphism and age at onset in Huntington disease. Neurology 65 : 964 965.
2. Alcantara S, Frisen J, del Rio JA, Soriano E, Barbacid M, Silos-Santiago I (1997) TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death. J Neurosci 17 : 3623 3633.
3. Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL et al (1997) Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389 : 856 860.
4. Angelucci F, Aloe L, Iannitelli A, Gruber SH, Mathe AA (2005) Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain. Eur Neuropsychopharmacol 15 : 311 317.
5. Bai O, Chlan-Fourney J, Bowen R, Keegan D, Li XM (2003) Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. J Neurosci Res 71 : 127 131.
6. Baquet ZC, Gorski JA, Jones KR (2004) Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci 24 : 4250 4258.
7. Barde YA, Edgar D, Thoenen H (1982) Purification of a new neurotrophic factor from mammalian brain. EMBO J 1 : 549 553.
8. Binder DK, Scharfman HE (2004) Brain-derived neurotrophic factor. Growth Factors 22 : 123 131.
9. Bova R, Micheli MR, Qualadrucci P, Zucconi GG (1998) BDNF and trkB mRNAs oscillate in rat brain during the light-dark cycle. Brain Res Mol Brain Res 57 : 321 324.
10. Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martin-Ibanez R, Munoz MT et al (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J Neurosci 24 : 7727 7739.
11. Castren E, Voikar V, Rantamaki T (2007) Role of neurotrophic factors in depression. Curr Opin Pharmacol 7 : 18 21.
12. Chen WG, West AE, Tao X, Corfas G, Szentirmay MN, Sawadogo M et al (2003) Upstream stimulatory factors are mediators of Ca2+-responsive transcription in neurons. J Neurosci 23 : 2572 2581.
13. Dechant G, Barde YA (2002) The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nat Neurosci 5 : 1131 1136.
14. Duan W, Guo Z, Jiang H, Ware M, Li XJ, Mattson MP (2003) Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci USA 100 : 2911 2916.
15. Ferrer I, Goutan E, Marin C, Rey MJ, Ribalta T (2000) Brain-derived neurotrophic factor in Huntington disease. Brain Res 866 : 257 261.
16. Gauthier LR, Charrin BC, Borrell-Pages M, Dompierre JP, Rangone H, Cordelieres FP et al (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118 : 127 138.
17. Gellera C, Meoni C, Castellotti B, Zappacosta B, Girotti F, Taroni F, DiDonato S (1996) Errors in Huntington disease diagnostic test caused by trinucleotide deletion in the IT15 gene. Am J Hum Genet 59 : 475 477.
18. Gines S, Bosch M, Marco S, Gavalda N, Diaz-Hernandez M, Lucas JJ et al (2006) Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain. Eur J Neurosci 23 : 649 658.
19. Ginsberg SD, Che S, Wuu J, Counts SE, Mufson EJ (2006) Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J Neurochem 97 : 475 487.
20. Haapasalo A, Sipola I, Larsson K, Akerman KE, Stoilov P, Stamm S et al (2002) Regulation of TRKB surface expression by brain-derived neurotrophic factor and truncated TRKB isoforms. J Biol Chem 277 : 43160 43167.
21. Hermel E, Gafni J, Propp SS, Leavitt BR, Wellington CL, Young JE et al (2004) Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death Differ 11 : 424 438.
22. Hock C, Heese K, Hulette C, Rosenberg C, Otten U (2000) Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 57 : 846 851.
23. Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G et al (2006) Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet 15 : 965 977.
24. Ivkovic S, Ehrlich ME (1999) Expression of the striatal DARPP-32/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro. J Neurosci 19 : 5409 5419.
25. Johnson R, Gamblin RJ, Ooi L, Bruce AW, Donaldson IJ, Westhead DR et al (2006) Identification of the REST regulon reveals extensive transposable element-mediated binding site duplication. Nucleic Acids Res 34 : 3862 3877.
26. Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R (2005) Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 136 : 29 37.
27. Katoh-Semba R, Takeuchi IK, Semba R, Kato K (1997) Distribution of brain-derived neurotrophic factor in rats and its changes with development in the brain. J Neurochem 69 : 34 42.
28. Kolbeck R, Bartke I, Eberle W, Barde YA (1999) Brain-derived neurotrophic factor levels in the nervous system of wild-type and neurotrophin gene mutant mice. J Neurochem 72 : 1930 1938.
29. Liu QR, Walther D, Drgon T, Polesskaya O, Lesnick TG, Strain KJ et al (2005) Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet 134 : 93 103.
30. Martinez-Serrano A, Bjorklund A (1996) Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. J Neurosci 16 : 4604 4616.
31. Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y et al (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302 : 890 893.
32. Middlemas DS, Lindberg RA, Hunter T (1991) trkB, a neural receptor protein-tyrosine kinase: evidence for a full-length and two truncated receptors. Mol Cell Biol 11 : 143 153.
33. Mizuno K, Carnahan J, Nawa H (1994) Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Dev Biol 165 : 243 256.
34. Murer MG, Yan Q, Raisman-Vozari R (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 63 : 71 124.
35. Nagappan G, Lu B (2005) Activity-dependent modulation of the BDNF receptor TrkB: mechanisms and implications. Trends Neurosci 28 : 464 471.
36. Nakao N, Brundin P, Funa K, Lindvall O, Odin P (1995) Trophic and protective actions of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro. Brain Res Dev Brain Res 90 : 92 101.
37. Ozbas-Gerceker F, Gorter JA, Redeker S, Ramkema M, van der Valk P, Baayen JC et al (2004) Neurotrophin receptor immunoreactivity in the hippocampus of patients with mesial temporal lobe epilepsy. Neuropathol Appl Neurobiol 30 : 651 664.
38. Perez-Navarro E, Alberch J, Neveu I, Arenas E (1999) Brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4/5 differentially regulate the phenotype and prevent degenerative changes in striatal projection neurons after excitotoxicity in vivo. Neuroscience 91 : 1257 1264.
39. Perez-Navarro E, Canudas AM, Akerund P, Alberch J, Arenas E (2000) Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease. J Neurochem 75 : 2190 2199.
40. Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T (2007) Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 90 : 397 406.
41. Reichardt LF (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361 : 1545 1564.
42. Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 85 : 5733 5737.
43. Rigamonti D, Bolognini D, Mutti C, Zuccato C, Tartari M, Sola F et al (2007) Loss of huntingtin function complemented by small molecules acting as RE1/NRSE silencer modulators. J Biol Chem 282 : 24554 24562.
44. Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME et al (2003) Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60 : 1615 1620.
45. Rosas HD, Hevelone ND, Zaleta AK, Greve DN, Salat DH, Fischl B (2005) Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 65 : 745 747.
46. Spires TL, Grote HE, Varshney NK, Cordery PM, van Dellen A, Blakemore C, Hannan AJ (2004) Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism. J Neurosci 24 : 2270 2276.
47. Stoilov P, Castren E, Stamm S (2002) Analysis of the human TrkB gene genomic organization reveals novel TrkB isoforms, unusual gene length, and splicing mechanism. Biochem Biophys Res Commun 290 : 1054 1065.
48. Tan J, Shepherd RK (2006) Aminoglycoside-induced degeneration of adult spiral ganglion neurons involves differential modulation of tyrosine kinase B and p75 neurotrophin receptor signaling. Am J Pathol 169 : 528 543.
49. Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME (1998) Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20 : 709 726.
50. Teng HK, Teng KK, Lee R, Wright S, Tevar S, Almeida RD et al (2005) ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci 25 : 5455 5463.
51. The Huntington's Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 : 971 983.
52. Trottier Y, Devys D, Imbert G, Saudou F, An I, Lutz Y et al (1995) Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat Genet 10 : 104 110.
53. Ventimiglia R, Mather PE, Jones BE, Lindsay RM (1995) The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J Neurosci 7 : 213 222.
54. Widmer HR, Hefti F (1994) Neurotrophin-4/5 promotes survival and differentiation of rat striatal neurons developing in culture. Eur J Neurosci 6 : 1669 1679.
55. Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P et al (2002) Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron 33 : 849 860.
56. Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington's disease. Prog Neurobiol 81 : 294 330.
57. Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L et al (2001) Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's disease. Science 293 : 493 498.
58. Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L et al (2003) Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 35 : 76 83.
59. Zuccato C, Liber D, Ramos C, Tarditi A, Rigamonti D, Tartari M et al (2005) Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery. Pharmacol Res 52 : 133 139.
60. Zuccato C, Tartari M, Goffredo D, Cattaneo E, Rigamonti D (2005) From target identification to drug screening assays for neurodegenerative diseases. Pharmacol Res 52 : 245 251.
61. Zuccato C, Belyaev N, Conforti P, Ooi L, Tartari M, Papadimou E et al (2007) Widespread disruption of REST/NRSF occupancy of its target genes in Huntington's disease. J Neurosci 27 : 6972 6983.